Cargando…

Editorial: Progressive fibrosing interstitial lung disease: from bench to bedside

Detalles Bibliográficos
Autores principales:	Guiot, Julien, Njock, Makon-Sébastien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505784/ https://www.ncbi.nlm.nih.gov/pubmed/37727756 http://dx.doi.org/10.3389/fmed.2023.1277909

Ejemplares similares

Progressive fibrosing interstitial lung disease in rheumatoid arthritis: A retrospective study
por: Denis, Anna, et al.
Publicado: (2022)

The Burden of Progressive-Fibrosing Interstitial Lung Diseases
por: Cottin, Vincent, et al.
Publicado: (2022)

The Role of Radiology in Progressive Fibrosing Interstitial Lung Disease
por: Abu Qubo, Ahmad, et al.
Publicado: (2022)

Management of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD)
por: Copeland, Carla R., et al.
Publicado: (2021)

Editorial: Sarcoidosis and autoimmunity: From bench to bedside
por: d'Alessandro, Miriana
Publicado: (2023)

Exosomal miRNAs in Lung Diseases: From Biologic Function to Therapeutic Targets
por: Guiot, Julien, et al.
Publicado: (2019)

Editorial: New insights into autoinflammatory diseases: from bench to bedside
por: Ammouri, Wafa
Publicado: (2023)

Progression of fibrosing interstitial lung disease
por: Wong, Alyson W., et al.
Publicado: (2020)

Present and future perspectives in early diagnosis and monitoring for progressive fibrosing interstitial lung diseases
por: Stanel, Stefan Cristian, et al.
Publicado: (2023)

Biomarkers in Progressive Fibrosing Interstitial Lung Disease: Optimizing Diagnosis, Prognosis, and Treatment Response
por: Bowman, Willis S., et al.
Publicado: (2021)

Editorial: New insights in sarcoidosis: from bench to bedside
por: Cameli, Paolo, et al.
Publicado: (2023)

Editorial: Cardio-Oncology: From Bench to Bedside
por: Abe, Jun-ichi, et al.
Publicado: (2019)

Editorial: Updates on ulcerative colitis and Crohn's disease: from bench to bedside
por: D'Andrea, Vito, et al.
Publicado: (2023)

Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries
por: Hilberg, Ole, et al.
Publicado: (2022)

Exosomal Long Non-Coding RNAs in Lung Diseases
por: Poulet, Christophe, et al.
Publicado: (2020)

Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ?
por: Guiot, Julien, et al.
Publicado: (2022)

The natural history of progressive fibrosing interstitial lung diseases
por: Kolb, Martin, et al.
Publicado: (2019)

The natural history of progressive fibrosing interstitial lung diseases
por: Brown, Kevin K., et al.
Publicado: (2020)

Predictors of Mortality in Progressive Fibrosing Interstitial Lung Diseases
por: Chen, Xianqiu, et al.
Publicado: (2021)

Acute exacerbations of progressive-fibrosing interstitial lung diseases
por: Kolb, Martin, et al.
Publicado: (2018)

Role of imaging in progressive-fibrosing interstitial lung diseases
por: Walsh, Simon L.F., et al.
Publicado: (2018)

Burden of illness in progressive fibrosing interstitial lung disease
por: Singer, David, et al.
Publicado: (2022)

Editorial: Ischemic Myocardial Injury and Protection: From Bench to Bedside
por: Gong, Hui, et al.
Publicado: (2022)

Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study)
por: Nasser, Mouhamad, et al.
Publicado: (2021)

Portopulmonary Hypertension: From Bench to Bedside
por: Thomas, Christopher, et al.
Publicado: (2020)

Editorial: Innovative Approaches to Tackle Atrial Fibrillation: From Bench to Bedside
por: Ai, Xun, et al.
Publicado: (2020)

Diagnostic and prognostic biomarkers for progressive fibrosing interstitial lung disease
por: Watase, Mayuko, et al.
Publicado: (2023)

Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases
por: Wollin, Lutz, et al.
Publicado: (2019)

Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
por: Cottin, Vincent, et al.
Publicado: (2021)

Progressive fibrosing interstitial lung disease: prevalence and clinical outcome
por: Kwon, Byoung Soo, et al.
Publicado: (2021)

Progressive Fibrosing Interstitial Lung Diseases: A Current Perspective
por: Albera, Carlo, et al.
Publicado: (2021)

Real-life prevalence of progressive fibrosing interstitial lung diseases
por: Gagliardi, Maureen, et al.
Publicado: (2021)

Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases
por: Brown, Kevin K., et al.
Publicado: (2022)

Management of Fibrosing Interstitial Lung Diseases
por: Maher, Toby M., et al.
Publicado: (2019)

Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
por: Cottin, Vincent
Publicado: (2019)

Editorial: Synaptopathies: from bench to bedside
por: Bramham, Clive R., et al.
Publicado: (2023)

The Burden of Progressive Fibrosing Interstitial Lung Disease: A DELPHI Approach
por: Wuyts, Wim A., et al.
Publicado: (2020)

Reply to comment on “The natural history of progressive fibrosing interstitial lung diseases”
por: Brown, Kevin K., et al.
Publicado: (2020)

Autoimmune Progressive Fibrosing Interstitial Lung Disease: Predictors of Fast Decline
por: Nagy, Alexandra, et al.
Publicado: (2021)

Management of patients with fibrosing interstitial lung diseases
por: Morrow, Lee E, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_el1hvc7lj8ottos81skd1bvcgd